Prognostic factors for patients after curative resection for proximal gastric cancer

Abstract

The factors influencing the long-term survival of patients with proximal gastric cancer (PGC) after curative resection were investigated. Data from 171 patients who underwent curative resection for PGC were retrospectively analyzed. The patients were grouped according to the clinicopathological factors and operative procedures. The tumor depth (T stage) and lymph node metastasis (pN stage) were graded according to the fifth edition of TNM Staging System published by UICC in 1997. The metastatic lymph node ratio (MLR) was divided into four levels: 0%, <10%, 10%–30% and >30%. The data of survival rate were analyzed by Kaplan-Meier method (log-rank test) and Cox regression model. The 5-year overall survival rate of 171 patients was 37.32%. The univariate analysis demonstrated that the survival time of the postoperative patients with PGC was related to tumor size (χ²=4.57, P=0.0325), gross type (χ²=21.38, P<0.001), T stage (χ²=27.91, P<0.001), pN stage (χ²=44.72, P<0.001), MLR (χ²=61.12, P<0.001), TNM stage (χ²=44.91, P<0.001), and range of gastrectomy (χ²=4.36, P=0.0368). Multivariate analysis showed that MLR (χ²=10.972, P=0.001), pN stage (χ²=6.640, P=0.010), TNM stage (χ²=7.081, P=0.007), T stage (χ²=7.687, P=0.006) and gross type (χ²=6.252, P=0.012) were the independent prognostic factors. In addition, the prognosis of patients who underwent total gastrectomy (TG) was superior to that of patients who underwent proximal gastrectomy (PG) for the cases of tumor ≥5 cm (χ²=6.31, P=0.0120), Borrmann III/IV (χ²=7.96, P=0.0050), T4 (χ²=4.57, P=0.0325), pN2 (χ²=5.52, P=0.0188), MLR 10%–30% (χ²=4.46, P=0.0347), MLR >30% (χ²=13.34, P=0.0003), TNM III (χ²=14.05, P=0.0002) or TNM IV stage (χ²=4.37, P=0.0366); and combining splenectomy was beneficial to the cases of T3 (χ²=5.68, P=0.0171) or MLR >30% (χ²=6.11, P=0.0134). It was concluded that MLR, pN stage, TNM stage, T stage, and gross type had advantages in providing a precise prognostic evaluation for patients undergoing curative resection for PGC, in which MLR was the most valuable index. TG and combining splenectomy were useful to improve the prognosis to patients with PGC of TNM III/IV stage, serosa invasion, or extensive regional lymph node metastasis.

Keywords

stomach neoplasms / proximal gastric cancer / curative resection / prognosis

References

[1] VolpeC.M., DriscollD.L., DouglassH.O.Jr. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes. Ann Surg Oncol, 2000, 7(2): 139-144

[2] KimJ.H., ParkS.S., KimJ., et al.. Surgical outcomes for gastric cancer in the upper third of the stomach. World J Surg, 2006, 30(10): 1870-1876

[3] CraanenM.E., DekkerW., BlokP., et al.. Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastroenterol, 1992, 87(5): 572-579

[4] SiewertJ.R., BöttcherK., SteinH.J., et al.. Problem of proximal third gastric carcinoma. World J Surg, 1995, 19(4): 523-531

[5] CrewK.D., NeugutA.I.. Epidemiology of gastric cancer. World J Gastroenterol, 2006, 12(3): 354-362

[6] JacobC.E., Gama-RodriguesJ., BrescianiC.J., et al.. Trends in tumor location in gastric carcinoma over a 28-year period. Hepatogastroenterology, 2007, 54(76): 1297-1301

[7] HuangC.M., LinB.J., LuH.S., et al.. Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus. World J Gastroenterol, 2008, 14(27): 4383-4388

[8] PisoP., WernerU., LangH., et al.. Proximal versus distal gastric carcinoma — what are the differences?. Ann Surg Oncol, 2000, 7(7): 520-525

[9] PacelliF., PapaV., CaprinoP., et al.. Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. Am Surg, 2001, 67(7): 697-703

[10] KunisakiC., ShimadaH., OnoH.A., et al.. Comparison of results of surgery in the upper third and more distal stomach. J Gastrointest Surg, 2006, 10(5): 718-726

[11] YuW., ChioG.S., ChungH.Y.. Randomized clinical trial of splenectomy versus preservation in patients with proximal gastric cancer. Br J Surg, 2006, 93(5): 559-563

[12] KunisakiC., ShimadaH., NomuraM., et al.. Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach. Surgery, 2005, 137(2): 165-171

[13] KunisakiC., MakinoH., SuwaH., et al.. Impact of splenectomy in patients with gastric adenocarcinoma of the cardia. J Gastrointest Surg, 2007, 11(8): 1039-1044

[14] MonigS.P., ColletP.H., BaldusS.E., et al.. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol, 2001, 76(2): 89-92

[15] SakaguchiT., SawadaH., YamadaY., et al.. Indication of splenectomy for gastric carcinoma involving the proximal part of the stomach. Hepatogastroenterology, 2001, 48(38): 603-605

[16] ZhangX.F., HuangC.M., LuH.S., et al.. Surgical treatment and prognosis of gastric cancer in 2613 patients. World J Gastroenterol, 2004, 10(23): 3405-3408

[17] SobinL.H., FlemingI.D.. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer, 1997, 80(9): 1803-1804

[18] LiK., XuH.M., ChenJ.Q.. Relationship between metastatic rate and amount of lymph nodes and prognosis of gastric cancer. Zhonghua Yi Xue Za Zhi (Chinese), 2005, 85(30): 2113-2116

[19] YokotaT., IshiyamaS., SaitoT., et al.. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol, 2004, 39(4): 380-384

[20] WuZ.Y., LiJ.H., ZhanW.H., et al.. Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol, 2007, 13(30): 4122-4125

[21] HigashiH., NatsugoeS., IshigamiS., et al.. Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion. World J Surg, 2003, 27(4): 455-459

[22] DingY.B., ChenG.Y., XiaJ.G., et al.. Correlation of tumor-positive ratio and number of perigastric lymph nodes with prognosis of patients with surgically-removed gastric carcinoma. World J Gastroenterol, 2004, 10(2): 182-185

[23] NittiD., MarchetA., OlivieriM., et al.. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D₂ resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol, 2003, 10(9): 1077-1085

[24] YuJ.X., WuY.L., YangL.T.. The value of metastatic lymph nodes ratio in predicting the prognosis of patients with T3 gastric carcinoma. Zhonghua Yi Xue Za Zhi (Chinese), 2005, 85(13): 922-925

[25] ShiraishiN., AdachiY., KitanoS., et al.. Clinical outcome of proximal versus total gastrectomy for proximal gastric cancer. World J Surg, 2002, 26(9): 1150-1154

[26] IsgüderA.S., NazliO., TansugT., et al.. Total gastrectomy of gastric carcinoma. Hepatogastroenterology, 2005, 52(61): 302-304

[27] ZhangX.F., LuH.S., YinF.Z.. A comparative study of therapeutic effects of total versus proximal subtotal gastrectomy in adenocarcinoma of the gastric cardia. Zhonghua Zhong Liu Za Zhi (Chinese), 1994, 16(6): 447-450

[28] ErturkS., ErsanY., CicekY., et al.. Effect of simultaneous splenectomy on the survival of patients undergoing curative gastrectomy for proximal gastric carcinoma. Surg Today, 2003, 33(4): 254-258

[29] LeeK.Y., NohS.H., HyungW.J., et al.. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol, 2001, 8(5): 402-406

[30] CsendesA., BurdilesP., RojasJ., et al.. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery, 2002, 131(4): 401-407

[31] WeitzJ., JaquesD.P., BrennanM., et al.. Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer. Ann Surg Oncol, 2004, 11(7): 682-689

[32] IkeguchiM., KaibaraN.. Lymph node metastasis at the splenic hilum in proximal gastric cancer. Am Surg, 2004, 70(7): 645-648

[33] OhnoM., NakamuraT., AjikiT., et al.. Procedure for lymph node dissection around splenic artery in proximal gastric cancer. Hepatogastroenterology, 2003, 50(52): 1173-1177